<DOC>
	<DOCNO>NCT00891709</DOCNO>
	<brief_summary>The principal aim study obtain safety , tolerability pharmacokinetic data LEO 29102 administer cutaneously single multiple dos healthy male subject . The study divide one single dose part follow multiple dose part .</brief_summary>
	<brief_title>LEO 29102 Single Multiple Dose Study Dermal Application</brief_title>
	<detailed_description />
	<mesh_term>Dermatitis</mesh_term>
	<mesh_term>Dermatitis , Atopic</mesh_term>
	<mesh_term>Eczema</mesh_term>
	<criteria>Male adult age 18 55 year ( inclusive ) BMI 19 30 kg/m2 ( inclusive ) . Subjects must healthy determine medical history , physical examination , electrocardiogram ( ECG ) , blood pressuer heart rate , clinical laboratory evaluation . Subjects show sign eczema skin lesion . Subjects clinical sign allergic disease ( exclude non active hay fever ) .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>January 2010</verification_date>
</DOC>